NEW YORK--(BUSINESS WIRE)--Feb. 7, 2006--Callisto Pharmaceuticals, Inc. (AMEX:KAL) (FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, announced that it has completed a financing totaling approximately $5.14 million through a private placement involving common stock and warrants.
